Literature DB >> 32356858

Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit.

Francis Bessière1,2, Hugo Roccia3, Antoine Delinière1,2, Rome Charrière4, Philippe Chevalier1,2, Laurent Argaud3, Martin Cour2.   

Abstract

Year:  2020        PMID: 32356858      PMCID: PMC7195693          DOI: 10.1001/jamacardio.2020.1787

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  6 in total

1.  Race to find COVID-19 treatments accelerates.

Authors:  Kai Kupferschmidt; Jon Cohen
Journal:  Science       Date:  2020-03-27       Impact factor: 47.728

2.  Covid-19: six million doses of hydroxychloroquine donated to US despite lack of evidence.

Authors:  Elisabeth Mahase
Journal:  BMJ       Date:  2020-03-23

3.  Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

Authors:  Barbara J Drew; Michael J Ackerman; Marjorie Funk; W Brian Gibler; Paul Kligfield; Venu Menon; George J Philippides; Dan M Roden; Wojciech Zareba
Journal:  Circulation       Date:  2010-02-08       Impact factor: 29.690

Review 4.  Drug-induced QT Interval Prolongation in the Intensive Care Unit.

Authors:  Cecilia Villa Etchegoyen; Guillermo Alberto Keller; Sebastian Mrad; Sixuan Cheng; Guillermo Di Girolamo
Journal:  Curr Clin Pharmacol       Date:  2017

5.  Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.

Authors:  Jinoos Yazdany; Alfred H J Kim
Journal:  Ann Intern Med       Date:  2020-03-31       Impact factor: 25.391

6.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.